38 related articles for article (PubMed ID: 23796514)
1. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
[TBL] [Abstract][Full Text] [Related]
2. The winged helix domain of MORF binds CpG islands and the TAZ2 domain of p300.
Becht DC; Kanai A; Biswas S; Halawa M; Zeng L; Cox KL; Poirier MG; Zhou MM; Shi X; Yokoyama A; Kutateladze TG
iScience; 2024 Apr; 27(4):109367. PubMed ID: 38500836
[TBL] [Abstract][Full Text] [Related]
3. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways.
Duan L; Wu R; Zou Z; Wang H; Ye L; Li H; Yuan S; Li X; Zha H; Sun H; Zhang Y; Chen X; Zhou L
Int J Oncol; 2014 Mar; 44(3):781-90. PubMed ID: 24378749
[TBL] [Abstract][Full Text] [Related]
4. S100A6 Protein-Expression and Function in Norm and Pathology.
Leśniak W; Filipek A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674873
[TBL] [Abstract][Full Text] [Related]
5. S100A6 as a Constituent and Potential Marker of Adult and Cancer Stem Cells.
Leśniak W; Filipek A
Stem Cell Rev Rep; 2022 Dec; 18(8):2699-2708. PubMed ID: 35796891
[TBL] [Abstract][Full Text] [Related]
6. The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases.
Sattar Z; Lora A; Jundi B; Railwah C; Geraghty P
Pulm Med; 2021; 2021():5488591. PubMed ID: 34239729
[TBL] [Abstract][Full Text] [Related]
7. S100A6 and Its Brain Ligands in Neurodegenerative Disorders.
Filipek A; Leśniak W
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492924
[TBL] [Abstract][Full Text] [Related]
8. S100A6/miR193a regulates the proliferation, invasion, migration and angiogenesis of lung cancer cells through the P53 acetylation.
Li P; Lv X; Zhang Z; Xie S
Am J Transl Res; 2019; 11(8):4634-4649. PubMed ID: 31497188
[TBL] [Abstract][Full Text] [Related]
9. Expression profile and functional role of S100A14 in human cancer.
Basnet S; Sharma S; Costea DE; Sapkota D
Oncotarget; 2019 Apr; 10(31):2996-3012. PubMed ID: 31105881
[TBL] [Abstract][Full Text] [Related]
10. TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.
Magni M; Buscemi G; Maita L; Peng L; Chan SY; Montecucco A; Delia D; Zannini L
Cell Death Differ; 2019 May; 26(5):918-931. PubMed ID: 30050056
[TBL] [Abstract][Full Text] [Related]
11. c-Fos-dependent miR-22 targets MDC1 and regulates DNA repair in terminally differentiated cells.
Lee JH; Park SJ; Kim SW; Hariharasudhan G; Jung SM; Jun S; Yong J; Jin You H
Oncotarget; 2017 Jul; 8(29):48204-48221. PubMed ID: 28637007
[TBL] [Abstract][Full Text] [Related]
12. S100A6 protein: functional roles.
Donato R; Sorci G; Giambanco I
Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
[TBL] [Abstract][Full Text] [Related]
13. Distinct prognostic values of S100 mRNA expression in breast cancer.
Zhang S; Wang Z; Liu W; Lei R; Shan J; Li L; Wang X
Sci Rep; 2017 Jan; 7():39786. PubMed ID: 28051137
[TBL] [Abstract][Full Text] [Related]
14. p53 Acetylation: Regulation and Consequences.
Reed SM; Quelle DE
Cancers (Basel); 2014 Dec; 7(1):30-69. PubMed ID: 25545885
[TBL] [Abstract][Full Text] [Related]
15. S100A6 competes with the TAZ2 domain of p300 for binding to p53 and attenuates p53 acetylation.
Graczyk A; Słomnicki LP; Leśniak W
J Mol Biol; 2013 Sep; 425(18):3488-94. PubMed ID: 23796514
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
[TBL] [Abstract][Full Text] [Related]
17. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
18. S100A6 binds p53 and affects its activity.
Słomnicki ŁP; Nawrot B; Leśniak W
Int J Biochem Cell Biol; 2009 Apr; 41(4):784-90. PubMed ID: 18765292
[TBL] [Abstract][Full Text] [Related]
19. S100A6 - new facts and features.
Leśniak W; Słomnicki ŁP; Filipek A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1087-92. PubMed ID: 19891957
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]